Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy

被引:545
作者
Famous, Katie R. [1 ]
Delucchi, Kevin [2 ]
Ware, Lorraine B. [6 ,7 ]
Kangelaris, Kirsten N. [3 ]
Liu, Kathleen D. [4 ,5 ]
Thompson, B. Taylor [8 ]
Calfee, Carolyn S. [1 ,5 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA
[6] Vanderbilt Univ, Dept Med, Nashville, TN USA
[7] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA
[8] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
subphenotype; acute lung injury; fluid therapy; ACUTE LUNG INJURY; LATENT CLASS ANALYSIS; PLASMA ANGIOPOIETIN-2; CATHETER; ARDS;
D O I
10.1164/rccm.201603-0645OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: We previously identified two acute respiratory distress syndrome (ARDS) subphenotypes in two separate randomized controlled trials with differential response to positive end-expiratory pressure. Objectives: To identify these subphenotypes in a third ARDS cohort, to test whether subphenotypes respond differently to fluid management strategy, and to develop a practical model for subphenotype identification. Methods: We used latent class analysis of baseline clinical and plasma biomarker data to identify subphenotypes in FACTT (Fluid and Catheter Treatment Trial; n = 1,000). Logistic regression was used to test for an interaction between subphenotype and treatment for mortality. We used stepwise modeling to generate a model for subphenotype identification in FACTT and validated its accuracy in the two cohorts in which we previously identified ARDS subphenotypes. Measurements and Main Results: We confirmed that a two-class (two-subphenotype) model best described the study population. Subphenotype 2 was again characterized by higher inflammatory biomarkers and hypotension. Fluid management strategy had significantly different effects on 90-day mortality in the two subphenotypes (P = 0.0039 for interaction); mortality in subphenotype 1 was 26% with fluid-conservative strategy versus 18% with fluid-liberal, whereas mortality in subphenotype 2 was 40% with fluid-conservative strategy versus 50% in fluid-liberal. A three variable model of IL-8, bicarbonate, and tumor necrosis factor receptor-1 accurately classified the subphenotypes. Conclusions: This analysis confirms the presence of two ARDS subphenotypes that can be accurately identified with a limited number of variables and that responded differently to randomly assigned fluid management. These findings support the presence of ARDS subtypes that may require different treatment approaches.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 18 条
  • [1] Plasma Angiopoietin-2 Predicts the Onset of Acute Lung Injury in Critically III Patients
    Agrawal, Ashish
    Matthay, Michael A.
    Kangelaris, Kirsten N.
    Stein, John
    Chu, Jeffrey C.
    Imp, Brandon M.
    Cortez, Alfredo
    Abbott, Jason
    Liu, Kathleen D.
    Calfee, Carolyn S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (07) : 736 - 742
  • [2] [Anonymous], 2002, Latent Class Analysis
  • [3] Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death
    Bhandari, Vineet
    Choo-Wing, Rayman
    Lee, Chun G.
    Zhu, Zhou
    Nedrelow, Jonathan H.
    Chupp, Geoffrey L.
    Zhang, Xucher
    Matthay, Michael A.
    Ware, Lorraine B.
    Homer, Robert J.
    Lee, Patty J.
    Geick, Anke
    de Fougerolles, Antonin R.
    Elias, Jack A.
    [J]. NATURE MEDICINE, 2006, 12 (11) : 1286 - 1293
  • [4] Elevated Levels of the Receptor for Advanced Glycation End Products, a Marker of Alveolar Epithelial Type I Cell Injury, Predict Impaired Alveolar Fluid Clearance in Isolated Perfused Human Lungs
    Briot, Raphael
    Frank, James A.
    Uchida, Tokujiro
    Lee, Jae W.
    Calfee, Carolyn S.
    Matthay, Michael A.
    [J]. CHEST, 2009, 135 (02) : 269 - 275
  • [5] Brower RG, 2004, NEW ENGL J MED, V351, P327
  • [6] Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
    Brower, RG
    Matthay, MA
    Morris, A
    Schoenfeld, D
    Thompson, BT
    Wheeler, A
    Wiedemann, HP
    Arroliga, AC
    Fisher, CJ
    Komara, JJ
    Perez-Trepichio, P
    Parsons, PE
    Wolkin, R
    Welsh, C
    Fulkerson, WJ
    MacIntyre, N
    Mallatratt, L
    Sebastian, M
    McConnell, R
    Wilcox, C
    Govert, J
    Thompson, D
    Clemmer, T
    Davis, R
    Orme, J
    Weaver, L
    Grissom, C
    Eskelson, M
    Young, M
    Gooder, V
    McBride, K
    Lawton, C
    d'Hulst, J
    Peerless, JR
    Smith, C
    Brownlee, J
    Pluss, W
    Kallet, R
    Luce, JM
    Gottlieb, J
    Elmer, M
    Girod, A
    Park, P
    Daniel, B
    Gropper, M
    Abraham, E
    Piedalue, F
    Glodowski, J
    Lockrem, J
    McIntyre, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1301 - 1308
  • [7] Distinct Molecular Phenotypes of Direct vs Indirect ARDS in Single-Center and Multicenter Studies
    Calfee, Carolyn S.
    Janz, David R.
    Bernard, Gordon R.
    May, Addison K.
    Kangelaris, Kirsten N.
    Matthay, Michael A.
    Ware, Lorraine B.
    [J]. CHEST, 2015, 147 (06) : 1539 - 1548
  • [8] Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials
    Calfee, Carolyn S.
    Delucchi, Kevin
    Parsons, Polly E.
    Thompson, B. Taylor
    Ware, Lorraine B.
    Matthay, Michael A.
    [J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (08) : 611 - 620
  • [9] Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance
    Calfee, Carolyn S.
    Gallagher, Diana
    Abbott, Jason
    Thompson, B. Taylor
    Matthay, Michael A.
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (06) : 1731 - 1737
  • [10] Famous KR, 2016, AM J RESP CRIT CARE, V193